CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
Kimihiko Kaneko(Fukushima Medical University), Masashi Aoki(Tohoku University), Yuji Hashimoto(Chiba Kaihin Municipal Hospital), Ryo Ogawa(Fukushima Medical University), Dagoberto Callegaro(Universidade de São Paulo), Shuhei Nishiyama(Fukushima Medical University), Toshiyuki Takahashi(Fukushima Medical University), Satoru Tanaka(Saitama Medical University), Ichiro Nakashima(Tohoku University), Lawrence Steinman(Stanford University), Kazuo Fujihara(Tohoku University), Hiroshi Kuroda(Fukushima Medical University), Douglas Kazutoshi Sato(Fukushima Medical University), Yoshiki Takai(Fukushima Medical University), Tetsuya Akaishi(Tohoku University Hospital), Kyoichi Nomura(Saitama Medical University), Tatsuro Misu(Fukushima Medical University)
Cited by 199
Related Papers
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
1,25-Dihydroxyvitamin D <sub>3</sub> Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A
|Molecular and Cellular Biology|2011|456
Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
|Nature Medicine|2007|448
MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
|Neurology Neuroimmunology & Neuroinflammation|2017|432